Alterations in Behavioral Responses to a Cholinergic Agonist in Post-Pubertal Rats with Neonatal Ventral Hippocampal Lesions: Relationship to Changes in Muscarinic Receptor Levels

Excitotoxic neonatal ventral hippocampal (NVH) lesion in rats is considered as a putative animal model of schizophrenia as lesioned animals show characteristic post-pubertal emergence of neurochemical and behavioral abnormalities analogous to some of those seen in this disease. Converging evidence points to the involvement of central cholinergic system in this neuropsychiatric disorder, and our previous studies have suggested that cholinergic neurotransmission may be altered in post-pubertal NVH lesioned rats. We investigated here muscarinic receptor reactivity in NVH lesioned animals by measuring the effects of the muscarinic receptor agonist oxotremorine on physiological responses known to be modulated by these receptors such as body temperature, salivation, tremor, pain, and prepulse inhibition of the acoustic startle (PPI). Quantitative receptor autoradiography revealed that post-pubertal NVH lesioned animals display increased levels of [3H]pirenzepine/M1-like and [3H]AFDX-384/M2-like receptor binding sites in the striatum, nucleus accumbens, and in subareas of the dorsal hippocampus. Moreover, in response to the systemic administration of oxotremorine (0.25 mg/kg), post-pubertal NVH lesioned rats exhibited increases in salivation and tremor, and a greater reduction in body temperature compared to sham control animals. Increases in the hot-plate latency were also observed suggesting enhanced antinociceptive effects of oxotremorine in post-pubertal NVH lesioned animals. Finally, oxotremorine (0.1 and 0.25 mg/kg) disrupted PPI in post-pubertal sham control rats while the muscarinic receptor antagonist biperiden (0.5 and 1.0 mg/kg) normalized this behavior in NVH lesioned rats. Taken together, these findings reveal that post-pubertal NVH lesioned rats display enhanced muscarinic receptor responsiveness, which may relate to some behavioral abnormalities reported in this animal model.

[1]  J. Callicott.  An expanded role for functional neuroimaging in schizophrenia , 2003, Current Opinion in Neurobiology.

[2]  N. Swerdlow,et al.  Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine , 1995, Psychopharmacology.

[3]  R. Russell,et al.  Potential animal model of multiple chemical sensitivity with cholinergic supersensitivity. , 1996, Toxicology.

[4]  M. Meaney,et al.  Long-term effects of BIBN-99, a selective muscarinic M2 receptor antagonist, on improving spatial memory performance in aged cognitively impaired rats , 2003, Behavioural Brain Research.

[5]  S. Harte,et al.  Involvement of the intralaminar parafascicular nucleus in muscarinic-induced antinociception in rats , 2004, Brain Research.

[6]  W. W. Baker,et al.  Analysis of the tremor induced by injection of cholinergic agents into the caudate nucleus. , 1966, International journal of neuropharmacology.

[7]  H. Hermesh,et al.  Abnormal thermoregulation in drug-free male schizophrenia patients , 2001, European Neuropsychopharmacology.

[8]  Edilio Borroni,et al.  Prepulse inhibition deficits of the startle reflex in neonatal ventral hippocampal–lesioned rats: reversal by glycine and a glycine transporter inhibitor , 2003, Biological Psychiatry.

[9]  B. Bogerts,et al.  Alterations of the dopaminergic and glutamatergic neurotransmission in adult rats with postnatal ibotenic acid hippocampal lesion , 1999, Psychopharmacology.

[10]  Daniel R. Weinberger,et al.  Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood , 1997, Psychopharmacology.

[11]  T. Hyde,et al.  Cholinergic systems and schizophrenia: primary pathology or epiphenomena? , 2001, Journal of Chemical Neuroanatomy.

[12]  D. Weinberger,et al.  Postpubertal Emergence of Hyperresponsiveness to Stress and to Amphetamine after Neonatal Excitotoxic Hippocampal Damage: A Potential Animal Model of Schizophrenia , 1993, Neuropsychopharmacology.

[13]  E. Neafsey,et al.  Prefrontal cortical control of the autonomic nervous system: anatomical and physiological observations. , 1990, Progress in brain research.

[14]  E. Richelson,et al.  Clozapine is a potent and selective muscarinic antagonist at the five cloned human muscarinic acetylcholine receptors expressed in CHO-K1 cells. , 1991, European journal of pharmacology.

[15]  M. Herkenham,et al.  Phencyclidine (angel dust)/sigma "opiate" receptor: visualization by tritium-sensitive film. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Weinberger,et al.  Excitotoxic Lesions of the Rat Medial Prefrontal Cortex: Effects on Abnormal Behaviors Associated with Neonatal Hippocampal Damage , 1998, Neuropsychopharmacology.

[17]  S. Hardy.  Analgesia elicited by prefrontal stimulation , 1985, Brain Research.

[18]  Emil Kraepelin,et al.  Dementia praecox and paraphrenia , 2002 .

[19]  S. Lightowler,et al.  The muscarinic receptor agonist xanomeline has an antipsychotic-like profile in the rat. , 2001, The Journal of pharmacology and experimental therapeutics.

[20]  B. Bogerts,et al.  Disruption of Latent Inhibition in Rats with Postnatal Hippocampal Lesions , 1999, Neuropsychopharmacology.

[21]  J. Yeomans,et al.  Increased drinking in mutant mice with truncated M5 muscarinic receptor genes , 2002, Pharmacology Biochemistry and Behavior.

[22]  B. Dean,et al.  Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment. , 2001, The American journal of psychiatry.

[23]  J. Wess,et al.  Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Daniel R. Weinberger,et al.  Prefrontal neurons and the genetics of schizophrenia , 2001, Biological Psychiatry.

[25]  H. Schnitzler,et al.  Induction of Fos-protein in the forebrain and disruption of sensorimotor gating following N-methyl-d-aspartate infusion into the ventral hippocampus of the rat , 1998, Neuroscience.

[26]  M. Koch.  The septohippocampal system is involved in prepulse inhibition of the acoustic startle response in rats. , 1996, Behavioral neuroscience.

[27]  A. Parent,et al.  Facilitation of acetylcholine release and cognitive performance by an M(2)-muscarinic receptor antagonist in aged memory-impaired , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[28]  Rémi Quirion,et al.  Alterations in dopaminergic modulation of prefrontal cortical acetylcholine release in post‐pubertal rats with neonatal ventral hippocampal lesions , 2004, Journal of neurochemistry.

[29]  B. Dean,et al.  The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia. , 1996, Molecular psychiatry.

[30]  Christian C Felder,et al.  Evaluation of muscarinic agonist-induced analgesia in muscarinic acetylcholine receptor knockout mice. , 2002, Molecular pharmacology.

[31]  Jaak Panksepp,et al.  Handbook of the hypothalamus , 1979 .

[32]  R. Tandon.  Cholinergic aspects of schizophrenia , 1999, British Journal of Psychiatry.

[33]  D. Weinberger,et al.  Neonatal Damage of the Ventral Hippocampus Impairs Working Memory in the Rat , 2002, Neuropsychopharmacology.

[34]  C. Sánchez,et al.  Central and peripheral mediation of hypothermia, tremor and salivation induced by muscarinic agonists in mice. , 1993, Pharmacology & toxicology.

[35]  R. Dworkin.  Pain insensitivity in schizophrenia: a neglected phenomenon and some implications. , 1994, Schizophrenia bulletin.

[36]  M. Eltze,et al.  Affinity and selectivity of biperiden enantiomers for muscarinic receptor subtypes. , 1988, European journal of pharmacology.

[37]  D. Weinberger,et al.  Neonatal hippocampal damage alters electrophysiological properties of prefrontal cortical neurons in adult rats. , 2002, Cerebral cortex.

[38]  J. Wess,et al.  Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine‐induced seizure activity , 2003, The European journal of neuroscience.

[39]  E. R. Marcotte,et al.  Animal models of schizophrenia: a critical review. , 2001, Journal of psychiatry & neuroscience : JPN.

[40]  R. Vertes.  Differential projections of the infralimbic and prelimbic cortex in the rat , 2004, Synapse.

[41]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[42]  R. Quirion,et al.  Decreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[43]  K. Nakano,et al.  Efferent projections of infralimbic and prelimbic areas of the medial prefrontal cortex in the Japanese monkey, Macaca fuscata , 2001, Brain Research.

[44]  Jeremy M Crook,et al.  Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation , 2000, Biological Psychiatry.

[45]  R. Tandon,et al.  Muscarinic cholinergic hyperactivity in schizophrenia relationship to positive and negative symptoms , 1991, Schizophrenia Research.

[46]  H. Shannon,et al.  Muscarinic cholinergic modulation of prepulse inhibition of the acoustic startle reflex. , 2000, The Journal of pharmacology and experimental therapeutics.

[47]  E. T. Iwamoto,et al.  Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats. , 1993, The Journal of pharmacology and experimental therapeutics.

[48]  J. Rochford,et al.  Selective mu and delta, but not kappa, opiate receptor antagonists inhibit the habituation of novelty-induced hypoalgesia in the rat , 2000, Psychopharmacology.

[49]  Y. Komiya,et al.  Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[50]  D. Westaway,et al.  Object Recognition Memory and Cholinergic Parameters in Mice Expressing Human Presenilin 1 Transgenes , 2002, Experimental Neurology.

[51]  R. Tandon,et al.  Cholinergic hyperactivity and negative symptoms: behavioral effects of physostigmine in normal controls , 1993, Schizophrenia Research.

[52]  G. Berntson,et al.  A central cholinergic link in the cardiovascular effects of the benzodiazepine receptor partial inverse agonist FG 7142 , 1996, Behavioural Brain Research.

[53]  M. Sarter.  Neuronal mechanisms of the attentional dysfunctions in senile dementia and schizophrenia: two sides of the same coin? , 1994, Psychopharmacology.

[54]  Douglas W. Jones,et al.  In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia. , 2003, The American journal of psychiatry.

[55]  G. Berntson,et al.  Cholinergic inputs to the rat medial prefrontal cortex mediate potentiation of the cardiovascular defensive response by the anxiogenic benzodiazepine receptor partial inverse agonist FG 7142 , 1999, Neuroscience.

[56]  J. Siegel,et al.  Cholinergic mechanisms in startle and prepulse inhibition: effects of the false cholinergic precursor N-aminodeanol. , 1993, Behavioral neuroscience.

[57]  S. Lautenbacher,et al.  Pain perception in psychiatric disorders: a review of the literature. , 1994, Journal of psychiatric research.

[58]  M. Sarter,et al.  Cognitive functions of cortical acetylcholine: toward a unifying hypothesis , 1997, Brain Research Reviews.

[59]  Abnormal regulation of corticopetal cholinergic neurons and impaired information processing in neuropsychiatric disorders , 1999 .

[60]  J. Wess,et al.  Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications. , 2004, Annual review of pharmacology and toxicology.

[61]  A. Levey,et al.  Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[62]  J. Seamans,et al.  Developing a Neuronal Model for the Pathophysiology of Schizophrenia Based on the Nature of Electrophysiological Actions of Dopamine in the Prefrontal Cortex , 1999, Neuropsychopharmacology.

[63]  Daniel R Weinberger,et al.  To Model a Psychiatric Disorder in Animals: Schizophrenia As a Reality Test , 2000, Neuropsychopharmacology.

[64]  S. G. Patrick Hardy,et al.  Prefrontal influences upon the midbrain: A possible route for pain modulation , 1985, Brain Research.

[65]  T. Robbins,et al.  Central cholinergic systems and cognition. , 1997, Annual review of psychology.

[66]  C. V. van Eden,et al.  Functional neuroanatomy of the prefrontal cortex: autonomic interactions. , 2000, Progress in brain research.

[67]  M. Caulfield.  Muscarinic receptors--characterization, coupling and function. , 1993, Pharmacology & therapeutics.

[68]  R. Gainetdinov,et al.  Muscarinic Supersensitivity and Impaired Receptor Desensitization in G Protein–Coupled Receptor Kinase 5–Deficient Mice , 1999, Neuron.

[69]  A. Gratton,et al.  Effects of neonatal ventral hippocampal lesion in rats on stress‐induced acetylcholine release in the prefrontal cortex , 2004, Journal of neurochemistry.

[70]  B. Dean,et al.  The binding of [3H]AF-DX 384 is reduced in the caudate-putamen of subjects with schizophrenia. , 1999, Life sciences.

[71]  M. Buuse.  Acute effects of antipsychotic drugs on cardiovascular responses to stress , 2003 .

[72]  R. Prado-Alcalá,et al.  Selective M1 muscarinic receptor antagonists disrupt memory consolidation of inhibitory avoidance in rats , 1997, Neuroscience Letters.

[73]  Philip Seeman,et al.  Radioreceptor Binding Profile of the Atypical Antipsychotic Olanzapine , 1996, Neuropsychopharmacology.

[74]  Bernhard Bogerts,et al.  Social behaviour in rats lesioned with ibotenic acid in the hippocampus: quantitative and qualitative analysis , 1999, Psychopharmacology.

[75]  G. Higgins,et al.  Spatial and associative learning deficits induced by neonatal excitotoxic hippocampal damage in rats: further evaluation of an animal model of schizophrenia , 2000, Behavioural pharmacology.

[76]  A. Gratton,et al.  Enhanced nucleus accumbens dopamine and plasma corticosterone stress responses in adult rats with neonatal excitotoxic lesions to the medial prefrontal cortex , 2000, Neuroscience.

[77]  W. W. Baker,et al.  Characteristics of tremor in cats following injections of carbachol into the caudate nucleus. , 1966, Experimental neurology.

[78]  B. Bogerts,et al.  Cellular changes in rat brain areas associated with neonatal hippocampal damage. , 1999, Neuroreport.